Administration of rIL-33 Restores Altered mDC/pDC Ratio, MDSC Frequency, and Th-17/Treg Ratio during Experimental Cerebral Malaria
Pathogens · 2024
DOI: 10.3390/pathogens13100877 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Saikat Mukherjee und 12 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Laboratory, Department of Zoology, University of Calcutta, 35, Ballygunge Circular Road, Kolkata 700019, West Bengal, India. Hauptthemen laut MEDLINE: Malaria, Cerebral, Interleukin-33, Th17 Cells, T-Lymphocytes, Regulatory. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indian Council of Medical Research, Council of Scientific and Industrial Research, Department of Science and Technology.
Abstract (Originalsprache)
The onset of malaria causes the induction of various inflammatory markers in the host’s body, which in turn affect the body’s homeostasis and create several cerebral complications. Polarization of myeloid-derived suppressor cells (MDSCs) from the classically activated M1 to alternatively activated M2 phenotype increases the secretion of pro-inflammatory molecules. Treatment with recombinant IL-33 (rIL-33) not only alters this MDSC’s polarization but also targets the glycolysis pathway of the metabolism in MDSCs, rendering them less immunosuppressive. Along with that, the Helper T-cells subset 17 (Th17)/T regulatory cells (Tregs) ratio is skewed towards Th17, which increases inflammation by producing more IL-17. However, treating with rIL-33 also helps to restore this ratio, which brings back homeostasis. During malaria infection, there is an upregulation of IL-12 production from dendritic cells along with a distorted myeloid dendritic cells (mDC)/plasmacytoid dendritic cells (pDC) ratio towards mDCs promoting inflammation. Administering rIL-33 will also subvert this IL-12 production and increase the population of pDC in the host’s immune system during malaria infection, thus restoring mDC/pDC to homeostasis. Therefore, treatment with rIL-33 to reduce the pro-inflammatory signatures and maintenance of immune homeostasis along with the increase in survivability could be a potential therapeutic approach for cerebral malaria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunology Laboratory, Department of Zoology, University of Calcutta, 35, Ballygunge Circular Road, Kolkata 700019, West Bengal, India.
- Centre for Infectious Medicine, Department of Medicine Huddinge, Karolinksa Institutet, 14152 Stockholm, Sweden.
- Center for Immunological and Inflammatory Diseases, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02129, USA.
Förderung
- Indian Council of Medical Research
- Council of Scientific and Industrial Research
- Department of Science and Technology
- Department of Science and Technology, Govt. of India
- DST-FIST
- UGC
Zitieren
APA
Mukherjee, S., Ghosh, P., Ghosh, S., Sengupta, A., Sarkar, S., Chatterjee, R., Saha, A., Bawali, S., Choudhury, A., Daptary, A. H., Gangopadhyay, A., Keswani, T., & Bhattacharyya, A. (2024). Administration of rIL-33 Restores Altered mDC/pDC Ratio, MDSC Frequency, and Th-17/Treg Ratio during Experimental Cerebral Malaria. Pathogens. https://doi.org/10.3390/pathogens13100877
Vancouver
Mukherjee S, Ghosh P, Ghosh S, Sengupta A, Sarkar S, Chatterjee R, et al. Administration of rIL-33 Restores Altered mDC/pDC Ratio, MDSC Frequency, and Th-17/Treg Ratio during Experimental Cerebral Malaria. Pathogens. 2024. doi:10.3390/pathogens13100877
BibTeX
@article{Mukherjee2024,
author = {Mukherjee, Saikat and Ghosh, Pronabesh and Ghosh, Soubhik and Sengupta, Anirban and Sarkar, Samrat and Chatterjee, Rimbik and Saha, Atreyee and Bawali, Sriparna and Choudhury, Abhishek and Daptary, Altamas Hossain and Gangopadhyay, Anwesha and Keswani, Tarun and Bhattacharyya, Arindam},
title = {Administration of rIL-33 Restores Altered mDC/pDC Ratio, MDSC Frequency, and Th-17/Treg Ratio during Experimental Cerebral Malaria},
journal = {Pathogens},
year = {2024},
doi = {10.3390/pathogens13100877}
}
EUVIMED